As GLP-1 pills for weight loss enter the U.S. market, some pharmaceutical companies are testing the possibility of a gene therapy to stimulate GLP-1 production, The Washington Post reported Jan. 24.

This opens the door to making mistakes—ones that could worsen your side effects, affect how much weight you’ll lose, or even ...

A once-weekly injectable glucose-dependent insulinotropic polypeptide/GLP-1 dual agonist conferred up to 14.7% weight loss at ...

Learn how new oral GLP-1 weight loss pills work, how they compare with injections, and how the next generation of “small ...

Regeneron Pharmaceuticals, Inc. nears a key earnings report after a strong JPM Healthcare update. Click here to find out why ...

GLP‑1 weight‑loss drugs are reshaping food industry demand, but side effects, cost barriers and unclear long‑term impacts ...

With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2 diabetes.

University Hospitals cardiologist explains the benefits, side effects, and future of these increasingly popular drugs.

MoneyShow presents top investment ideas for 2026 from leading advisors. Part 9 includes Target Corp., The Trade Desk, UFP ...

Everything from AI-generated videos of celebrities to fake online pharmacies are being used to try to dupe consumers ...

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

In January 2025, we reported about an observational study of nearly 2 million U.S. military veterans that showed a broad spectrum of possible risks and benefits associated with GLP-1 receptor agonists ...